201 related articles for article (PubMed ID: 36418348)
1. Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.
Bolouri H; Ries RE; Wiedeman AE; Hylkema T; Scheiding S; Gersuk VH; O'Brien K; Nguyen QA; Smith JL; Alice Long S; Meshinchi S
Nat Commun; 2022 Nov; 13(1):7186. PubMed ID: 36418348
[TBL] [Abstract][Full Text] [Related]
2. Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes.
Brandsma AM; Bertrums EJM; van Roosmalen MJ; Hofman DA; Oka R; Verheul M; Manders F; Ubels J; Belderbos ME; van Boxtel R
Blood Cancer Discov; 2021 Sep; 2(5):484-499. PubMed ID: 34642666
[TBL] [Abstract][Full Text] [Related]
3. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
4. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
[TBL] [Abstract][Full Text] [Related]
5. Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia.
Wang J; Tao Q; Wang H; Wang Z; Wu F; Pan Y; Tao L; Xiong S; Wang Y; Zhai Z
Hum Immunol; 2015 Sep; 76(9):681-6. PubMed ID: 26431888
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia.
Mei Y; Ren K; Liu Y; Ma A; Xia Z; Han X; Li E; Tariq H; Bao H; Xie X; Zou C; Zhang D; Li Z; Dong L; Verma A; Lu X; Abaza Y; Altman JK; Sukhanova M; Yang J; Ji P
J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 35900794
[TBL] [Abstract][Full Text] [Related]
7. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
9. The Gln223Arg polymorphism of the leptin receptor gene and peripheral blood/bone marrow leptin level in leukemic children.
Wasik M; Górska E; Popko K; Pawelec K; Matysiak M; Demkow U
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():375-83. PubMed ID: 17072067
[TBL] [Abstract][Full Text] [Related]
10. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.
Carey A; Edwards DK; Eide CA; Newell L; Traer E; Medeiros BC; Pollyea DA; Deininger MW; Collins RH; Tyner JW; Druker BJ; Bagby GC; McWeeney SK; Agarwal A
Cell Rep; 2017 Mar; 18(13):3204-3218. PubMed ID: 28355571
[TBL] [Abstract][Full Text] [Related]
11. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
[TBL] [Abstract][Full Text] [Related]
13. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
Cieniewicz B; Uyeda MJ; Chen PP; Sayitoglu EC; Liu JM; Andolfi G; Greenthal K; Bertaina A; Gregori S; Bacchetta R; Lacayo NJ; Cepika AM; Roncarolo MG
Haematologica; 2021 Oct; 106(10):2588-2597. PubMed ID: 33054128
[TBL] [Abstract][Full Text] [Related]
14. A new genomic framework to categorize pediatric acute myeloid leukemia.
Umeda M; Ma J; Westover T; Ni Y; Song G; Maciaszek JL; Rusch M; Rahbarinia D; Foy S; Huang BJ; Walsh MP; Kumar P; Liu Y; Yang W; Fan Y; Wu G; Baker SD; Ma X; Wang L; Alonzo TA; Rubnitz JE; Pounds S; Klco JM
Nat Genet; 2024 Feb; 56(2):281-293. PubMed ID: 38212634
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal single-cell atlas of treatment response in pediatric AML.
Lambo S; Trinh DL; Ries RE; Jin D; Setiadi A; Ng M; Leblanc VG; Loken MR; Brodersen LE; Dai F; Pardo LM; Ma X; Vercauteren SM; Meshinchi S; Marra MA
Cancer Cell; 2023 Dec; 41(12):2117-2135.e12. PubMed ID: 37977148
[TBL] [Abstract][Full Text] [Related]
16. HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
Abdul-Aziz AM; Shafat MS; Sun Y; Marlein CR; Piddock RE; Robinson SD; Edwards DR; Zhou Z; Collins A; Bowles KM; Rushworth SA
Oncogene; 2018 May; 37(20):2676-2686. PubMed ID: 29487418
[TBL] [Abstract][Full Text] [Related]
17. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
19. Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142.
Yuan DM; Ma J; Fang WB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9251-9258. PubMed ID: 31773676
[TBL] [Abstract][Full Text] [Related]
20. [Bone Marrow Osteoblasts Promotes the Proliferation Leukemia Stem Cell by Up-regulating Interleukin-1].
Cao ZJ; Li YS; Wang HJ; Xue ZY; Chen SY; Tang KJ; Wang M; Rao Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1348-1353. PubMed ID: 36208234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
